ECR 2022 will take place on July 13-17 in Vienna.
We are delighted to present three contributions related to MammoWave.
In these contributions, we will show some preliminary results obtained at Complejo Hospitalario Universitario de Toledo SESCAM in the context of our sponsored European multi-center clinical trial (activated thanks to #H2020 SME Instrument Phase 2)
We will also highlight:
– the potential benefits of MammoWave introduction in the breast screening protocol
– MammoWave performance improvement obtained via dedicated AI
algorithms (optimized in collaboration with London South Bank University)
